Loading…
Reported covered position: Legislative Director, Rep. Dingell
How to read the money
Income and expense are whole-filing amounts associated with this lobbyist, not personal compensation or an allocated share.
No topic inference: each bill number appears in source LDA issue text assigned to this lobbyist.
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: VIATRIS INC · Firm: VIATRIS INC.
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 3204, the Drug Quality and Security Act; Compounding; Generic Labeling; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, the Preserve Access to Affordable Generics; S. 504, the Fair and Immediate Release of Generic Drugs Act; H.R. 2725, the FDA Safety Over Sequestration Act of 2013; S. 621, the Safe Prescribing Act of 2013Risk Evaluation Mitigation Strategies; H.R. 460, Patients' Access to Treatments Act of 2013; implementation of the Generic Drug User Fee Act
Specific issues are shown only where the LDA source assigned them to this lobbyist. Targets apply to the associated filing.
2014 · second_quarter · Q2
Federal policy regarding Public Law 113-54, the Drug Quality and Security Act; FDA proposed rule, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products, Docket Number FDA-2013-N-0500, provisions relating to generic drug labeling changes; Proposed FDA rule, "Electronic Distribution of Prescribing Information for Human Prescription Drugs Including BiologicalProducts," RIN: 0910-AG18, provisions relating to the use of electronic package inserts for human pharmaceuticals and biologics; Implementations of Biosimilars in the Affordable Care Act (ACA), Biosimilar Naming, Implementation of FDASIA and Generic Drug User Fee Act; The Generic Drug Pricing Transparency Act, H.R. 4437; Risk Evaluation Mitigation Strategies, Potential legislation relating to the provision of brand drug products by brand manufacturers to generic manufacturers for development testing
Source: Senate LDA
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 3204, the Drug Quality and Security Act; Compounding; Generic Labeling; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, the Preserve Access to Affordable Generics; S. 504, the Fair and Immediate Release of Generic Drugs Act; H.R. 2725, the FDA Safety Over Sequestration Act of 2013; S. 621, the Safe Prescribing Act of 2013Risk Evaluation Mitigation Strategies; H.R. 460, Patients' Access to Treatments Act of 2013; implementation of the Generic Drug User Fee Act
Federal policy regarding Public Law 113-54, the Drug Quality and Security Act; FDA proposed rule, Supplemental Applications Proposing Labeling Changes for Approved Drugs and Biological Products, Docket Number FDA-2013-N-0500, provisions relating to generic drug labeling changes; Proposed FDA rule, "Electronic Distribution of Prescribing Information for Human Prescription Drugs Including BiologicalProducts," RIN: 0910-AG18, provisions relating to the use of electronic package inserts for human pharmaceuticals and biologics; Implementations of Biosimilars in the Affordable Care Act (ACA), Biosimilar Naming, Implementation of FDASIA and Generic Drug User Fee Act; The Generic Drug Pricing Transparency Act, H.R. 4437; Risk Evaluation Mitigation Strategies, Potential legislation relating to the provision of brand drug products by brand manufacturers to generic manufacturers for development testing
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 3204, the Drug Quality and Security Act; Compounding; Generic Labeling; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, the Preserve Access to Affordable Generics; S. 504, the Fair and Immediate Release of Generic Drugs Act; H.R. 2725, the FDA Safety Over Sequestration Act of 2013; S. 621, the Safe Prescribing Act of 2013Risk Evaluation Mitigation Strategies; H.R. 460, Patients' Access to Treatments Act of 2013; implementation of the Generic Drug User Fee Act
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 3204, the Drug Quality and Security Act; Compounding; Generic Labeling; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, the Preserve Access to Affordable Generics; S. 504, the Fair and Immediate Release of Generic Drugs Act; H.R. 2725, the FDA Safety Over Sequestration Act of 2013; S. 621, the Safe Prescribing Act of 2013Risk Evaluation Mitigation Strategies; H.R. 460, Patients' Access to Treatments Act of 2013; implementation of the Generic Drug User Fee Act
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 3204, the Drug Quality and Security Act; Compounding; Generic Labeling; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, the Preserve Access to Affordable Generics; S. 504, the Fair and Immediate Release of Generic Drugs Act; H.R. 2725, the FDA Safety Over Sequestration Act of 2013; S. 621, the Safe Prescribing Act of 2013Risk Evaluation Mitigation Strategies; H.R. 460, Patients' Access to Treatments Act of 2013; implementation of the Generic Drug User Fee Act
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 3204, the Drug Quality and Security Act; Compounding; Generic Labeling; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, the Preserve Access to Affordable Generics; S. 504, the Fair and Immediate Release of Generic Drugs Act; H.R. 2725, the FDA Safety Over Sequestration Act of 2013; S. 621, the Safe Prescribing Act of 2013Risk Evaluation Mitigation Strategies; H.R. 460, Patients' Access to Treatments Act of 2013; implementation of the Generic Drug User Fee Act
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 3204, the Drug Quality and Security Act; Compounding; Generic Labeling; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, the Preserve Access to Affordable Generics; S. 504, the Fair and Immediate Release of Generic Drugs Act; H.R. 2725, the FDA Safety Over Sequestration Act of 2013; S. 621, the Safe Prescribing Act of 2013Risk Evaluation Mitigation Strategies; H.R. 460, Patients' Access to Treatments Act of 2013; implementation of the Generic Drug User Fee Act
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: VIATRIS INC · Firm: VIATRIS INC.
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 3204, the Drug Quality and Security Act; Compounding; H.R. 2094 and S. 1503, the School Access to Emergency Epinephrine Act; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, the Preserve Access to Affordable GenericsS. 504, Fair and Immediate Release of Generic Drugs Act; H.R. 1285, S. 621, the Safe Prescribing Act of 2013; H.R. 460, Patients' Access to Treatments Act of 2013; H.R. 2725, the FDA Safety Over Sequestration Act 2013; S. 1545, the PEPFAR Stewardship and Oversight Act; Generic Labeling
To amend the Controlled Substances Act to make any substance containing hydrocodone a schedule II drug.
Client: VIATRIS INC · Firm: VIATRIS INC.
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 959, Pharmaceutical Quality, Security, and Affordability Act; H.R. 3204, Drug Quality and Security Act; Compounding; H.R. 2094 and S. 1503, the School Access to Emergency Epinephrine Act; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, Preserve Access to Affordable Generics ActS. 504, Fair and Immediate Release of Generic Drugs Act; H.R. 1285, S. 621, the Safe Prescribing Act of 2013; H.R. 460, Patients' Access to Treatments Act of 2013; H.R. 2725, the FDA Safety Over Sequestration Act 2013
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 959, Pharmaceutical Quality, Security, and Affordability Act; H.R. 3204, Drug Quality and Security Act; Compounding; H.R. 2094 and S. 1503, the School Access to Emergency Epinephrine Act; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, Preserve Access to Affordable Generics ActS. 504, Fair and Immediate Release of Generic Drugs Act; H.R. 1285, S. 621, the Safe Prescribing Act of 2013; H.R. 460, Patients' Access to Treatments Act of 2013; H.R. 2725, the FDA Safety Over Sequestration Act 2013
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 3204, the Drug Quality and Security Act; Compounding; H.R. 2094 and S. 1503, the School Access to Emergency Epinephrine Act; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, the Preserve Access to Affordable GenericsS. 504, Fair and Immediate Release of Generic Drugs Act; H.R. 1285, S. 621, the Safe Prescribing Act of 2013; H.R. 460, Patients' Access to Treatments Act of 2013; H.R. 2725, the FDA Safety Over Sequestration Act 2013; S. 1545, the PEPFAR Stewardship and Oversight Act; Generic Labeling
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 959, Pharmaceutical Quality, Security, and Affordability Act; H.R. 3204, Drug Quality and Security Act; Compounding; H.R. 2094 and S. 1503, the School Access to Emergency Epinephrine Act; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, Preserve Access to Affordable Generics ActS. 504, Fair and Immediate Release of Generic Drugs Act; H.R. 1285, S. 621, the Safe Prescribing Act of 2013; H.R. 460, Patients' Access to Treatments Act of 2013; H.R. 2725, the FDA Safety Over Sequestration Act 2013
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: VIATRIS INC · Firm: VIATRIS INC.
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 959, Pharmaceutical Quality, Security, and Affordability Act; H.R. 3204, Drug Quality and Security Act; Compounding; H.R. 2094 and S. 1503, the School Access to Emergency Epinephrine Act; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, Preserve Access to Affordable Generics ActS. 504, Fair and Immediate Release of Generic Drugs Act; H.R. 1285, S. 621, the Safe Prescribing Act of 2013; H.R. 460, Patients' Access to Treatments Act of 2013; H.R. 2725, the FDA Safety Over Sequestration Act 2013
Food and Drug Administration Safety Over Sequestration Act of 2013
Client: VIATRIS INC · Firm: VIATRIS INC.
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 3204, the Drug Quality and Security Act; Compounding; H.R. 2094 and S. 1503, the School Access to Emergency Epinephrine Act; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, the Preserve Access to Affordable GenericsS. 504, Fair and Immediate Release of Generic Drugs Act; H.R. 1285, S. 621, the Safe Prescribing Act of 2013; H.R. 460, Patients' Access to Treatments Act of 2013; H.R. 2725, the FDA Safety Over Sequestration Act 2013; S. 1545, the PEPFAR Stewardship and Oversight Act; Generic Labeling
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 3204, the Drug Quality and Security Act; Compounding; H.R. 2094 and S. 1503, the School Access to Emergency Epinephrine Act; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, the Preserve Access to Affordable GenericsS. 504, Fair and Immediate Release of Generic Drugs Act; H.R. 1285, S. 621, the Safe Prescribing Act of 2013; H.R. 460, Patients' Access to Treatments Act of 2013; H.R. 2725, the FDA Safety Over Sequestration Act 2013; S. 1545, the PEPFAR Stewardship and Oversight Act; Generic Labeling
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 959, Pharmaceutical Quality, Security, and Affordability Act; H.R. 3204, Drug Quality and Security Act; Compounding; H.R. 2094 and S. 1503, the School Access to Emergency Epinephrine Act; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, Preserve Access to Affordable Generics ActS. 504, Fair and Immediate Release of Generic Drugs Act; H.R. 1285, S. 621, the Safe Prescribing Act of 2013; H.R. 460, Patients' Access to Treatments Act of 2013; H.R. 2725, the FDA Safety Over Sequestration Act 2013
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 3204, the Drug Quality and Security Act; Compounding; H.R. 2094 and S. 1503, the School Access to Emergency Epinephrine Act; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, the Preserve Access to Affordable GenericsS. 504, Fair and Immediate Release of Generic Drugs Act; H.R. 1285, S. 621, the Safe Prescribing Act of 2013; H.R. 460, Patients' Access to Treatments Act of 2013; H.R. 2725, the FDA Safety Over Sequestration Act 2013; S. 1545, the PEPFAR Stewardship and Oversight Act; Generic Labeling
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 959, Pharmaceutical Quality, Security, and Affordability Act; H.R. 3204, Drug Quality and Security Act; Compounding; H.R. 2094 and S. 1503, the School Access to Emergency Epinephrine Act; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, Preserve Access to Affordable Generics ActS. 504, Fair and Immediate Release of Generic Drugs Act; H.R. 1285, S. 621, the Safe Prescribing Act of 2013; H.R. 460, Patients' Access to Treatments Act of 2013; H.R. 2725, the FDA Safety Over Sequestration Act 2013
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 959, Pharmaceutical Quality, Security, and Affordability Act; H.R. 3204, Drug Quality and Security Act; Compounding; H.R. 2094 and S. 1503, the School Access to Emergency Epinephrine Act; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, Preserve Access to Affordable Generics ActS. 504, Fair and Immediate Release of Generic Drugs Act; H.R. 1285, S. 621, the Safe Prescribing Act of 2013; H.R. 460, Patients' Access to Treatments Act of 2013; H.R. 2725, the FDA Safety Over Sequestration Act 2013
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 3204, the Drug Quality and Security Act; Compounding; H.R. 2094 and S. 1503, the School Access to Emergency Epinephrine Act; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, the Preserve Access to Affordable GenericsS. 504, Fair and Immediate Release of Generic Drugs Act; H.R. 1285, S. 621, the Safe Prescribing Act of 2013; H.R. 460, Patients' Access to Treatments Act of 2013; H.R. 2725, the FDA Safety Over Sequestration Act 2013; S. 1545, the PEPFAR Stewardship and Oversight Act; Generic Labeling
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 3204, the Drug Quality and Security Act; Compounding; H.R. 2094 and S. 1503, the School Access to Emergency Epinephrine Act; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, the Preserve Access to Affordable GenericsS. 504, Fair and Immediate Release of Generic Drugs Act; H.R. 1285, S. 621, the Safe Prescribing Act of 2013; H.R. 460, Patients' Access to Treatments Act of 2013; H.R. 2725, the FDA Safety Over Sequestration Act 2013; S. 1545, the PEPFAR Stewardship and Oversight Act; Generic Labeling
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 959, Pharmaceutical Quality, Security, and Affordability Act; H.R. 3204, Drug Quality and Security Act; Compounding; H.R. 2094 and S. 1503, the School Access to Emergency Epinephrine Act; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, Preserve Access to Affordable Generics ActS. 504, Fair and Immediate Release of Generic Drugs Act; H.R. 1285, S. 621, the Safe Prescribing Act of 2013; H.R. 460, Patients' Access to Treatments Act of 2013; H.R. 2725, the FDA Safety Over Sequestration Act 2013
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 3204, the Drug Quality and Security Act; Compounding; H.R. 2094 and S. 1503, the School Access to Emergency Epinephrine Act; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, the Preserve Access to Affordable GenericsS. 504, Fair and Immediate Release of Generic Drugs Act; H.R. 1285, S. 621, the Safe Prescribing Act of 2013; H.R. 460, Patients' Access to Treatments Act of 2013; H.R. 2725, the FDA Safety Over Sequestration Act 2013; S. 1545, the PEPFAR Stewardship and Oversight Act; Generic Labeling
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 3204, the Drug Quality and Security Act; Compounding; H.R. 2094 and S. 1503, the School Access to Emergency Epinephrine Act; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, the Preserve Access to Affordable GenericsS. 504, Fair and Immediate Release of Generic Drugs Act; H.R. 1285, S. 621, the Safe Prescribing Act of 2013; H.R. 460, Patients' Access to Treatments Act of 2013; H.R. 2725, the FDA Safety Over Sequestration Act 2013; S. 1545, the PEPFAR Stewardship and Oversight Act; Generic Labeling
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 959, Pharmaceutical Quality, Security, and Affordability Act; H.R. 3204, Drug Quality and Security Act; Compounding; H.R. 2094 and S. 1503, the School Access to Emergency Epinephrine Act; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, Preserve Access to Affordable Generics ActS. 504, Fair and Immediate Release of Generic Drugs Act; H.R. 1285, S. 621, the Safe Prescribing Act of 2013; H.R. 460, Patients' Access to Treatments Act of 2013; H.R. 2725, the FDA Safety Over Sequestration Act 2013
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 3204, the Drug Quality and Security Act; Compounding; H.R. 2094 and S. 1503, the School Access to Emergency Epinephrine Act; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, the Preserve Access to Affordable GenericsS. 504, Fair and Immediate Release of Generic Drugs Act; H.R. 1285, S. 621, the Safe Prescribing Act of 2013; H.R. 460, Patients' Access to Treatments Act of 2013; H.R. 2725, the FDA Safety Over Sequestration Act 2013; S. 1545, the PEPFAR Stewardship and Oversight Act; Generic Labeling
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 959, Pharmaceutical Quality, Security, and Affordability Act; H.R. 3204, Drug Quality and Security Act; Compounding; H.R. 2094 and S. 1503, the School Access to Emergency Epinephrine Act; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, Preserve Access to Affordable Generics ActS. 504, Fair and Immediate Release of Generic Drugs Act; H.R. 1285, S. 621, the Safe Prescribing Act of 2013; H.R. 460, Patients' Access to Treatments Act of 2013; H.R. 2725, the FDA Safety Over Sequestration Act 2013
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
Pharmaceutical Quality, Security, and Accountability Act
Client: VIATRIS INC · Firm: VIATRIS INC.
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
Pharmaceutical Quality, Security, and Accountability Act
Client: VIATRIS INC · Firm: VIATRIS INC.
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
Pharmaceutical Quality, Security, and Accountability Act
Client: VIATRIS INC · Firm: VIATRIS INC.
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 959, Pharmaceutical Quality, Security, and Affordability Act; H.R. 3204, Drug Quality and Security Act; Compounding; H.R. 2094 and S. 1503, the School Access to Emergency Epinephrine Act; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, Preserve Access to Affordable Generics ActS. 504, Fair and Immediate Release of Generic Drugs Act; H.R. 1285, S. 621, the Safe Prescribing Act of 2013; H.R. 460, Patients' Access to Treatments Act of 2013; H.R. 2725, the FDA Safety Over Sequestration Act 2013
Global Health Appropriations, President's Emergency Plan for AIDS Relief funding, Global Fund funding; FY 2015 Budget, FY 2015 House and Senate Appropriations, Funding for FDA, Funding for the Office of Generic Drug, Generice Drug User Fees
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2014 · first_quarter · Q1
Global Health Appropriations, President's Emergency Plan for AIDS Relief funding, Global Fund funding, FY2014 Budget, FY 2015 Budget, FY2015 Appropriations, Funding for FDA, Funding for the Office of Generic Drugs, Generic Drug User Fees, Biosimilar User Fees
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 3204, the Drug Quality and Security Act; Compounding; Generic Labeling; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, the Preserve Access to Affordable Generics; S. 504, the Fair and Immediate Release of Generic Drugs Act; H.R. 2725, the FDA Safety Over Sequestration Act of 2013; S. 621, the Safe Prescribing Act of 2013Risk Evaluation Mitigation Strategies; H.R. 460, Patients' Access to Treatments Act of 2013; implementation of the Generic Drug User Fee Act
Filing targets: Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
2013 · second_quarter · 2A
Global Health Appropriations, Presidents Emergency Plan for AIDS Relief, the Global Fund, FY 2014 Budget, FY 2013 Budget, Funding for FDA, Funding for the Office of Generic Drugs, FY14 Presidential Budget Request
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · fourth_quarter · Q4
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 3204, the Drug Quality and Security Act; Compounding; H.R. 2094 and S. 1503, the School Access to Emergency Epinephrine Act; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, the Preserve Access to Affordable GenericsS. 504, Fair and Immediate Release of Generic Drugs Act; H.R. 1285, S. 621, the Safe Prescribing Act of 2013; H.R. 460, Patients' Access to Treatments Act of 2013; H.R. 2725, the FDA Safety Over Sequestration Act 2013; S. 1545, the PEPFAR Stewardship and Oversight Act; Generic Labeling
Global Health Appropriations, President's Emergency Plan for AIDS Relief funding, Global Fund funding, FY2014 Budget, FY14 Appropriations, FY2013 Budget, Funding for FDA, Funding for the Office of Generic Drugs, Generic Drug User Fees, Biosimilar User Fees
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · third_quarter · Q3
Global Health Appropriations, President's Emergency Plan for AIDS Relief funding, Global Fund funding, FY2014 Budget, FY2013 Budget, Funding for FDA, Funding for the Office of Generic Drugs, Generic Drug User Fees, Biosimilar User Fees
Pharmaceutical Distribution Supply Chain Security; Electronic distribution of prescribing information; H.R. 1919, Safeguarding America's Pharmaceuticals Act of 2013; S. 959, Pharmaceutical Quality, Security, and Affordability Act; H.R. 3204, Drug Quality and Security Act; Compounding; H.R. 2094 and S. 1503, the School Access to Emergency Epinephrine Act; Biosimilars; H.R. 486, the Stop Tampering of Prescription Pills (STOPP) Act; S. 214, Preserve Access to Affordable Generics ActS. 504, Fair and Immediate Release of Generic Drugs Act; H.R. 1285, S. 621, the Safe Prescribing Act of 2013; H.R. 460, Patients' Access to Treatments Act of 2013; H.R. 2725, the FDA Safety Over Sequestration Act 2013
Filing targets: HOUSE OF REPRESENTATIVES, SENATE
2013 · second_quarter · Q2
Global Health Appropriations, Presidents Emergency Plan for AIDS Relief, the Global Fund, FY 2014 Budget, FY 2013 Budget, Funding for FDA, Funding for the Office of Generic Drugs, FY14 Presidential Budget Request
Pharmaceutical Distribution Supply Chain Security, Electronic distribution of prescribing information, H.R. 2094, the School Access to Emergency Epinephrine Act, S.214, Preserve Access to Affordable Generics Act, S.504, Fair and Immediate Release of Generic Drugs ActH.R.460 - Patients' Access to Treatments Act of 2013, Generic Drug User Fees, Biosimilar User Fees, Compounding, S. 959: Pharmaceutical Compounding Quality and Accountability Act, H.R. 1919: Safeguarding Americas Pharmaceuticals Act of 2013, S.957, the Drug Supply Chain Security Act, Global HIV/AIDS programs
Filing targets: HOUSE OF REPRESENTATIVES, SENATE